Early findings suggest some women with low-risk DCIS may avoid immediate surgery, although investigators caution that longer ...

By Dennis Thompson HealthDay ReporterTUESDAY, March 31, 2026 (HealthDay News) — A “watch and wait” approach might be best for ...

THOUSANDS of women with a common form of breast cancer may soon not need any treatment at all, scientists have suggested.

Researchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described early results as ...

A diagnosis of ductal carcinoma in situ, or DCIS, often comes as a surprise during a routine mammogram. While the news is understandably taxing, it is important to remember that DCIS is a noninvasive, ...

Large randomized trial makes case for non-inferiority versus surgery; smaller study falls ...

Thomas Jefferson University biostatistician Terry Hyslop designed a trial showing active monitoring to be as effective as ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DURHAM, N.C. (WNCN) — A Duke Researcher’s ...

NB: This will be the subject of an embargoed virtual news briefing Dr Antonio Esgueva at 14.00 hrs CET on Tuesday 15 November. Barcelona, Spain: Using ultrasound to guide surgery for patients with ...

Leesburg, VA, February 8, 2023—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), ultrafast (UF) MRI provides beneficial information that can be used in ...

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received ...